Autoimmune Hemolytic Anemia with Anti Jka Specificity in a Patient Taking Aldomet
- 10 September 1977
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 17 (5) , 517-520
- https://doi.org/10.1046/j.1537-2995.1977.17578014595.x
Abstract
Autoimmune hemolytic anemia (hemoglobin 5.2 g, reticulocyte count 31.0%) developed in a 53 yr old hypertensive woman who was taking Aldomet. The patient''s serum and the eluate prepared from her red blood cells contained an antibody with anti-Jka specificity. Rapid sustained improvement in the anemia occurred after cessation of Aldomet and a 2 wk course of prednisone therapy. Eight months later, anti-Jka was no longer detectable in the patient''s serum and the direct antiglobulin test was nonreactive.This publication has 5 references indexed in Scilit:
- Autoimmune Hemolytic Anemia in Hodgkin's Disease Associated with Anti‐ITTransfusion, 1974
- Auto‐Immune Hemolytic Anemia Caused by Anti‐UVox Sanguinis, 1971
- Anti‐LW Specificity in Autoimmune Acquired Hemolytic AnemiaTransfusion, 1967
- INCIDENCE OF A POSITIVE DIRECT COOMBS TEST IN PATIENTS ON α-METHYLDOPAThe Lancet, 1966
- Antibody elution from red blood cellsJournal of Clinical Pathology, 1963